These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7110533)

  • 1. Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine.
    Fuller RW; Hemrick-Luecke SK
    Neuropharmacology; 1982 May; 21(5):433-8. PubMed ID: 7110533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats.
    Fuller RW; Hemrick-Luecke S
    Science; 1980 Jul; 209(4453):305-7. PubMed ID: 7384808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.
    Steranka LR
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):198-204. PubMed ID: 6145099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MK801 antagonism of the prolonged depletion of striatal dopamine by amphetamine in iprindole-treated rats.
    Hemrick-Luecke SK; Henderson MG; Fuller RW
    Life Sci; 1992; 50(6):PL31-3. PubMed ID: 1734157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.
    Nash JF; Yamamoto BK
    Brain Res; 1993 Nov; 627(1):1-8. PubMed ID: 7904885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administration.
    Henderson MG; Hemrick-Luecke S; Fuller RW
    Ann N Y Acad Sci; 1992 May; 648():286-8. PubMed ID: 1379012
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against amphetamine-induced neurotoxicity toward striatal dopamine neurons in rodents by LY274614, an excitatory amino acid antagonist.
    Fuller RW; Hemrick-Luecke SK; Ornstein PL
    Neuropharmacology; 1992 Oct; 31(10):1027-32. PubMed ID: 1436384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP.
    Steranka LR; Rhind AW
    Eur J Pharmacol; 1987 Jan; 133(2):191-7. PubMed ID: 3493165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    Henderson MG; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1993 Oct; 267(1):417-24. PubMed ID: 8229770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-tetrahydropyridine (MPTP) in rodents.
    Fuller RW; Steranka LR
    Life Sci; 1985 Jan; 36(3):243-7. PubMed ID: 3871244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Neural Transm Gen Sect; 1994; 96(3):165-77. PubMed ID: 7826568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
    Braestrup C
    J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct in vivo monitoring of dopamine released from two striatal compartments in the rat.
    Ewing AG; Bigelow JC; Wightman RM
    Science; 1983 Jul; 221(4606):169-71. PubMed ID: 6857277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion.
    Ricaurte GA; Guillery RW; Seiden LS; Schuster CR
    Brain Res; 1984 Jan; 291(2):378-82. PubMed ID: 6697198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain.
    Peat MA; Warren PF; Gibb JW
    J Pharmacol Exp Ther; 1983 Apr; 225(1):126-31. PubMed ID: 6187915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA; Shore PA
    J Pharm Pharmacol; 1978 Jul; 30(7):464-6. PubMed ID: 27622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.